NCT07727668
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,146 public trials
2,034 recruiting studies
Lymphoproliferative Disorders trial results
Not yet recruiting
Weight Gain in Pediatric Leukemia Survivors
NCT07374315
- Conditions
- Behavior, Body Weight, Health Behavior, +21 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
Not yet recruiting
A Study of KIV-318 Injection in Patients With BCMA-Positive Relapsed/Refractory Multiple Myeloma
NCT07726160
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, China
Not yet recruiting
Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple Myeloma
NCT07725406
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +23 more
- Locations
-
- Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States
Not yet recruiting
Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL)
NCT07717580
- Conditions
- Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Peking University First Hospital Beijing, Beijing Municipality, China
Not yet recruiting
A Study of Injectable BLB101 and Blincyto® in Adult Participants With R/R CD19+ B-ALL
NCT07723911
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
Not specified
Not yet recruiting
Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System
NCT07721350
- Conditions
- Amyloidosis, Behavior, Blood Protein Disorders, +21 more
- Locations
-
- Hôpital Lyon-Sud Pierre-Bénite, France
NCT07719855
- Conditions
- Follicular Lymphoma ( FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Ruijin Hosiptal Shanghai, Shanghai Municipality, China
Not yet recruiting
TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM)
NCT07720843
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
Not specified
Not yet recruiting
INfections in Patients Treated With CAR-T
NCT07713511
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bloodstream Infections, +29 more
- Locations
-
- IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy